Arginine hydrochloride (HCl) is an amino acid derivative used as an excipient in pharmaceutical formulations [1]. It serves as a stabilizer, buffering agent, and solubilizer in various drug products, particularly for protein-based therapeutics [1][2].
What does arginine HCl do in a drug?
Arginine HCl plays a crucial role in maintaining the stability and efficacy of drug formulations. As a stabilizer, it helps prevent protein aggregation and degradation, which is vital for biologics like monoclonal antibodies [1][3]. Its buffering capacity assists in controlling the pH of the formulation, ensuring optimal conditions for drug solubility and shelf life [1]. Arginine HCl can also enhance the solubility of certain active pharmaceutical ingredients (APIs), facilitating their delivery [2].
When does the patent for arginine HCl expire?
Arginine HCl is a well-established chemical compound and is not typically patented as a standalone ingredient. Patents usually cover specific formulations, manufacturing processes, or novel uses of excipients like arginine HCl in combination with an API [4]. Therefore, the patent expiry relevant to arginine HCl would be tied to the patents of the specific drugs in which it is used [4]. Information on patent expiry for specific drug products can be found through resources like DrugPatentWatch.com [5].
How is arginine HCl used in biologics?
In biologics, particularly protein therapeutics, arginine HCl is frequently included in the formulation to improve stability [1][3]. Proteins are susceptible to various stresses that can lead to unfolding, aggregation, or chemical degradation. Arginine HCl acts as a stabilizing excipient by interacting with the protein surface, reducing unfavorable hydrophobic interactions and maintaining the protein's native conformation [1][3]. This is critical for ensuring that the biologic drug remains active and safe for patients throughout its shelf life [3].
Are there alternatives to arginine HCl for drug formulation?
Yes, alternative excipients can be used in drug formulations depending on the specific API and desired properties. Other amino acids, such as histidine or proline, can also function as stabilizers or buffering agents [1]. Carbohydrates like sucrose or trehalose are common cryoprotectants and lyoprotectants for biologics [3]. Surfactants like polysorbates can help prevent protein aggregation at interfaces [3]. The choice of excipient depends on compatibility with the API, the intended route of administration, and the required stability profile [1][3].